News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety updates   FDA warn of skin injury with OTC rubefacients Rare cases of serious burns on the skin have been reported to the US Food and Drug Administration (FDA) where over-the-counter (OTC) topical muscle and joint […]

Read More…

SHORTCUTS

Cancer. 2012 Chemotherapy use and patient treatment preferences in advanced colorectal cancer: A prospective cohort study.   Zafar SY, Malin JL, Grambow SC, Abbott DH, Kolimaga JT, Zullig LL, Weeks JC, Ayanian JZ, Kahn KL, Ganz PA, Catalano PJ, West DW, Provenzale D; for the Cancer Care Outcomes Research & Surveillance (CanCORS) Consortium. This national […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Hot topics   Liverpool Care Pathway consensus statement Over 20 organisations have signed a consensus statement in support of the Liverpool Care Pathway for the dying patient, including professional bodies, third sector organizations, disease specific charities and […]

Read More…

SHORTCUTS

Ann Surg Oncol. 2012 Nov 10. [Epub ahead of print] Longitudinal Changes in Function, Symptom Burden, and Quality of Life in Patients with Early-Stage Lung Cancer. Koczywas M, Williams AC, Cristea M, Reckamp K, Grannis Jr FW, Tiep BL, Uman G, Ferrell B. This study evaluated the longitudinal changes (up to 1 year) in physical […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Hot topics   DH consultation: Governance arrangements for controlled drugs The Department of Health (DH) is consulting on proposed changes to the governance arrangements for controlled drugs in England and Scotland, including the role and functions of […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Drug updates   Ketamine injection supply problems Pfizer UK has confirmed that there is a supply problem with ketamine (Ketalar) 10mg/mL and 100mg/mL injection. All orders for these products are now being re-directed to a Pfizer central […]

Read More…

SHORTCUTS

Articles of interest in other scholarly journals   Pain outcomes in patients with advanced breast cancer and bone metastases: Results from a randomized, double-blind study of denosumab and zoledronic acid. Cleeland CS, Body JJ, Stopeck A, von Moos R, Fallowfield L, Mathias SD, Patrick DL, Clemons M, Tonkin K, Masuda N, Lipton A, de Boer […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Drug updates NICE final draft guidance for denosumab The UK National Institute for Health and Clinical Excellence (NICE) has published final draft guidance on the use of denosumab for the treatment of bone metastases from solid tumours […]

Read More…

SHORTCUTS

Articles of interest in other scholarly journals.   Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? a qualitative study Miriam J Johnson, Laura Sheard, Anthony Maraveyas, Simon Noble, Hayley Prout, Ian Watt and Dawn Dowding Using think aloud exercises and interviews of oncologists, palliative physicians and general practitioners, […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website.   Safety updates NPSA insulin passport deadline NHS organisations should ensure that by 31 August 2012 the following actions, outlined in the National Patient Safety Agency (NPSA) alert ‘The adult patient’s passport for safer use of insulin’ (NPSA/2011/PSA003), […]

Read More…